Monash IVF Group Limited (ASX:MVF)
0.8500
-0.0200 (-2.30%)
Nov 27, 2025, 4:10 PM AEST
Monash IVF Group Revenue
In the fiscal year ending June 30, 2025, Monash IVF Group had annual revenue of 271.92M AUD with 6.54% growth. Monash IVF Group had revenue of 131.53M in the half year ending June 30, 2025, with 19.06% growth.
Revenue
271.92M
Revenue Growth
+6.54%
P/S Ratio
1.22
Revenue / Employee
304.84K
Employees
892
Market Cap
331.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 271.92M | 16.69M | 6.54% |
| Jun 30, 2024 | 255.23M | 41.43M | 19.38% |
| Jun 30, 2023 | 213.80M | 21.50M | 11.18% |
| Jun 30, 2022 | 192.29M | 8.69M | 4.73% |
| Jun 30, 2021 | 183.61M | 38.19M | 26.26% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |